Remove Hormones Remove Insulin Remove Vaccination
article thumbnail

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.

article thumbnail

COVID-19 May Trigger New-Onset Diabetes

XTalks

Related: Moderna’s COVID-19 Vaccine Effective Against New Variants. While type 2 diabetes is associated with inflammation, which could potentially explain the link between a COVID-19 infection and ensuing inflammatory response, the reasons for the onset of insulin-dependent type I diabetes is a bit less clear.

Insulin 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

Section 351 of the Public Health Service (PHS) Act defines a biological product as a “virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product. Biologics include a wide range of products , including: Vaccines. Definition of Biologic Products. Allergenics.

article thumbnail

Sebastian MacLean’s Naturally Massive

The Pharma Data

Physique developers around the world are amazed that… …using natural food and training techniques, you can increase your body’s normal production of growth producing hormone! Going back to the drawing board and looking for ways to restart my body’s natural hormone output, I came across an amazing discovery.

article thumbnail

Tjoapack and Biopharma: Our Packaging Options

Pharma Packaging Solutions

Pre-filled Syringe Packaging A lot of biopharmaceutical products—such as insulin, vaccines, and many hormone therapies—are parenterally administered. We offer a variety of solutions designed to meet your biologics packaging requirements, no matter how complex.

article thumbnail

From Gene to Protein: The Journey of Protein Expression Technology

Roots Analysis

The rising demand for protein therapeutics, such as monoclonal antibodies and vaccines , is driving advancements in protein expression technology to ensure efficient and scalable production.

Protein 40
article thumbnail

Subcutaneous Biologics: The Unmet Requirement in the Pharmaceutical Space

Roots Analysis

These devices can be used for controlled delivery of small molecules, as well as large macromolecules ( such as insulin, growth hormones, immunobiological vaccine, receptor agonist, proteins and peptides ). This can be attributed to their relatively more efficient and patient friendly mode of drug delivery.